Yüklüyor......

A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways

Exposure to the EGFR (epidermal growth factor receptor) inhibitor erlotinib promotes the dynamic rewiring of apoptotic pathways, which sensitizes cells within a specific period to subsequent exposure to the DNA-damaging agent doxorubicin. A critical challenge for translating this therapeutic network...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Morton, Stephen W., Lee, Michael J., Deng, Zhou J., Dreaden, Erik C., Siouve, Elise, Shopsowitz, Kevin E., Shah, Nisarg J., Yaffe, Michael B., Hammond, Paula T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138219/
https://ncbi.nlm.nih.gov/pubmed/24825919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.2005261
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!